skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 14,538  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Prescription Drugs remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction
Material Type:
Article
Add to My Research

Correction

Journal of the American College of Cardiology, 2017-02, Vol.69 (5), p.601 [Peer Reviewed Journal]

Copyright Elsevier Limited Feb 7, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.12.008

Full text available

2
No money for new drugs
Material Type:
Article
Add to My Research

No money for new drugs

Nature (London), 2020-10, Vol.586 (7830), p.S50-S52 [Peer Reviewed Journal]

Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-02884-3

Full text available

3
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Material Type:
Article
Add to My Research

Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

Pharmaceutical research, 2008-04, Vol.25 (4), p.781-791 [Peer Reviewed Journal]

US Government: Food and Drug Administration 2007 ;2008 INIST-CNRS ;Springer Science+Business Media, LLC 2008 ;ISSN: 0724-8741 ;EISSN: 1573-904X ;DOI: 10.1007/s11095-007-9511-1 ;PMID: 18185986 ;CODEN: PHREEB

Full text available

4
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

The lancet oncology, 2016-07, Vol.17 (7), p.917-927 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30107-3 ;PMID: 27279544 ;CODEN: LANCAO

Full text available

5
Opioid Crisis: No Easy Fix to Its Social and Economic Determinants
Material Type:
Article
Add to My Research

Opioid Crisis: No Easy Fix to Its Social and Economic Determinants

American journal of public health (1971), 2018-02, Vol.108 (2), p.182-186 [Peer Reviewed Journal]

Copyright American Public Health Association Feb 2018 ;American Public Health Association 2018 2018 ;ISSN: 0090-0036 ;EISSN: 1541-0048 ;DOI: 10.2105/AJPH.2017.304187 ;PMID: 29267060

Full text available

6
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission
Material Type:
Article
Add to My Research

Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission

The Lancet (British edition), 2022-02, Vol.399 (10324), p.555-604 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02252-2 ;PMID: 35122753

Full text available

7
Trends in Opioid Analgesic Abuse and Mortality in the United States
Material Type:
Article
Add to My Research

Trends in Opioid Analgesic Abuse and Mortality in the United States

The New England journal of medicine, 2015-01, Vol.372 (3), p.241-248 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsa1406143 ;PMID: 25587948

Full text available

8
WHAT HAPPENED TO THE 'GAME CHANGING' COVID DRUG PAXLOVID?
Material Type:
Article
Add to My Research

WHAT HAPPENED TO THE 'GAME CHANGING' COVID DRUG PAXLOVID?

Nature (London), 2023-01, Vol.613 (7943), p.224-225 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jan 12, 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-04576-6

Full text available

9
Sex differences in pharmacokinetics predict adverse drug reactions in women
Material Type:
Article
Add to My Research

Sex differences in pharmacokinetics predict adverse drug reactions in women

Biology of sex differences, 2020-06, Vol.11 (1), p.32-14, Article 32 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2042-6410 ;EISSN: 2042-6410 ;DOI: 10.1186/s13293-020-00308-5 ;PMID: 32503637

Full text available

10
How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis
Material Type:
Article
Add to My Research

How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis

Mayo Clinic proceedings, 2018-03, Vol.93 (3), p.344-350 [Peer Reviewed Journal]

2017 Mayo Foundation for Medical Education and Research ;Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Frontline Medical Communications Inc. ;COPYRIGHT 2018 Elsevier, Inc. ;Copyright Mayo Foundation for Medical Education and Research Mar 2018 ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.1016/j.mayocp.2017.12.020 ;PMID: 29502564

Full text available

11
The natural history of an epidemic
Material Type:
Article
Add to My Research

The natural history of an epidemic

Nature (London), 2019-09, Vol.573 (7773), p.S10-S12 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 12, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-019-02686-2

Full text available

12
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum
Material Type:
Article
Add to My Research

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2018-01, Vol.41 (1), p.14-31 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Jan 1, 2018 ;2017 by the American Diabetes Association. 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci17-0057 ;PMID: 29263194

Full text available

13
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Material Type:
Article
Add to My Research

New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013, p.627375-25 [Peer Reviewed Journal]

Copyright © 2013 Si-Yuan Pan et al. ;Copyright © 2013 Si-Yuan Pan et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2013 Si-Yuan Pan et al. 2013 ;ISSN: 1741-427X ;EISSN: 1741-4288 ;DOI: 10.1155/2013/627375 ;PMID: 23634172

Full text available

14
The illusive trade-off: intellectual property rights, innovation systems, and Egypt's pharmaceutical industry
Material Type:
Book
Add to My Research

The illusive trade-off: intellectual property rights, innovation systems, and Egypt's pharmaceutical industry

The illusive trade-off, 2006, Vol.27, p.xii-xii

2006 University of Toronto Press Incorporated ;ISBN: 1442681489 ;ISBN: 9781442681484 ;ISBN: 0802091806 ;ISBN: 9780802091802 ;EISBN: 1442681489 ;EISBN: 9781442681484 ;DOI: 10.3138/9781442681484 ;OCLC: 752277501 ;OCLC: 923070280 ;OCLC: 654415376 ;LCCallNum: HD9673.E3 A33 2006eb

Digital Resources/Online E-Resources

15
NHS England drive sees almost half a million people started on anticoagulant drugs
Material Type:
Article
Add to My Research

NHS England drive sees almost half a million people started on anticoagulant drugs

BMJ (Online), 2023-11, Vol.383, p.p2567-2567 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.p2567

Full text available

16
The global preventable cost of cancer drug wastage
Material Type:
Article
Add to My Research

The global preventable cost of cancer drug wastage

The lancet oncology, 2023-09, Vol.24 (9), p.956-956 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(23)00381-9 ;PMID: 37517409

Full text available

17
The $2.6 Billion Pill — Methodologic and Policy Considerations
Material Type:
Article
Add to My Research

The $2.6 Billion Pill — Methodologic and Policy Considerations

The New England journal of medicine, 2015-05, Vol.372 (20), p.1877-1879 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1500848 ;PMID: 25970049

Full text available

18
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Material Type:
Article
Add to My Research

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Gut, 2012-12, Vol.61 (12), p.1693-1700 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2011-301668 ;PMID: 22595313 ;CODEN: GUTTAK

Full text available

19
Doctors in India raise concerns about new mandate to prescribe generically or risk suspension
Material Type:
Article
Add to My Research

Doctors in India raise concerns about new mandate to prescribe generically or risk suspension

BMJ (Online), 2023-08, Vol.382, p.p1930-1930 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.p1930

Full text available

20
Drug Companies’ Liability for the Opioid Epidemic
Material Type:
Article
Add to My Research

Drug Companies’ Liability for the Opioid Epidemic

The New England journal of medicine, 2017-12, Vol.377 (24), p.2301-2305 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1710756 ;PMID: 29236640

Full text available

Results 1 - 20 of 14,538  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,374)

Refine My Results

New Records 

  1. New From Last Week  (1)
  2. New From Last Month  (15)
  3. New From Last 3 Month  (66)
  4. More options open sub menu

Subject 

  1. Pharmaceutical Industry  (14,471)
  2. Fda Approval  (2,551)
  3. Generic Drugs  (2,440)
  4. Drug Stores  (2,362)
  5. Science & Technology  (2,316)
  6. Life Sciences & Biomedicine  (2,181)
  7. Medicare  (2,018)
  8. Patients  (1,863)
  9. Drugs  (1,839)
  10. Health Care Policy  (1,685)
  11. Marketing  (1,677)
  12. Pharmacy  (1,589)
  13. R&d  (1,458)
  14. Research & Development  (1,452)
  15. Humans  (1,433)
  16. Physicians  (1,431)
  17. Pharmacists  (1,178)
  18. Pharmaceuticals  (1,158)
  19. Cost Control  (1,113)
  20. More options open sub menu

Language 

  1. English  (14,520)
  2. Japanese  (139)
  3. French  (15)
  4. Portuguese  (11)
  5. Spanish  (5)
  6. German  (3)
  7. Polish  (2)
  8. Chinese  (2)
  9. Hungarian  (1)
  10. Slovenian  (1)
  11. Dutch  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait